Practical considerations for therapies targeting the prostacyclin pathway

Therapies that target the prostacyclin pathway play a key role in the treatment of both early- and late-stage pulmonary arterial hypertension, and provide significant clinical benefits for patients. A number of agents have been approved, which are administered via intravenous, subcutaneous, inhaled...

Descripción completa

Detalles Bibliográficos
Autores principales: Farber, Harrison W., Gin-Sing, Wendy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2016
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487556/
https://www.ncbi.nlm.nih.gov/pubmed/27903664
http://dx.doi.org/10.1183/16000617.0083-2016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487556/
https://www.ncbi.nlm.nih.gov/pubmed/27903664
http://dx.doi.org/10.1183/16000617.0083-2016

Ejemplares similares